Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahea
- Posted on March 20, 2026
- By Business News Today
- 3 Views
Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahea
Pharma stocks rose up to 4% as Novo Nordisks semaglutide patent nears expiry, raising expectations of cheaper generics in India. Strong growth potential in GLP-1 drugs, low penetration, and aggressive pricing by domestic players like Natco Pharma are driving investor interest in the sector.
